Intravitreal faricimab for neovascular age-related macular degeneration previously treated with traditional anti-VEGF compounds: a real-world prospective study.

Grimaldi, Gabriela; Cancian, Giuseppe; Rizzato, Angelica; Casanova, Alex; Perruchoud-Ader, Kathrin; Clerici, Michele; Consigli, Andrea; Menghini, Moreno

Grimaldi, Gabriela; Cancian, Giuseppe; Rizzato, Angelica; Casanova, Alex; Perruchoud-Ader, Kathrin; Clerici, Michele; Consigli, Andrea; Menghini, Moreno.

Afiliação

Grimaldi G; Department of Ophthalmology, Institute of Clinical Neurosciences of Southern Switzerland (INSI), Ente Ospedaliero Cantonale (EOC), Lugano, Switzerland. gabriela.grimaldi@eoc.ch.
Cancian G; Department of Ophthalmology, Institute of Clinical Neurosciences of Southern Switzerland (INSI), Ente Ospedaliero Cantonale (EOC), Lugano, Switzerland.
Rizzato A; Department of Ophthalmology, Institute of Clinical Neurosciences of Southern Switzerland (INSI), Ente Ospedaliero Cantonale (EOC), Lugano, Switzerland.
Casanova A; Department of Ophthalmology, Institute of Clinical Neurosciences of Southern Switzerland (INSI), Ente Ospedaliero Cantonale (EOC), Lugano, Switzerland.
Perruchoud-Ader K; Department of Ophthalmology, Institute of Clinical Neurosciences of Southern Switzerland (INSI), Ente Ospedaliero Cantonale (EOC), Lugano, Switzerland.
Clerici M; Department of Ophthalmology, Institute of Clinical Neurosciences of Southern Switzerland (INSI), Ente Ospedaliero Cantonale (EOC), Lugano, Switzerland.
Consigli A; Department of Ophthalmology, Institute of Clinical Neurosciences of Southern Switzerland (INSI), Ente Ospedaliero Cantonale (EOC), Lugano, Switzerland.
Menghini M; Department of Ophthalmology, Institute of Clinical Neurosciences of Southern Switzerland (INSI), Ente Ospedaliero Cantonale (EOC), Lugano, Switzerland.

Graefes Arch Clin Exp Ophthalmol ; 262(4): 1151-1159, 2024 Apr.

Article em En | MEDLINE | ID: mdl-38047930

Assuntos

Anticorpos Biespecíficos; Degeneração Macular; Degeneração Macular Exsudativa; Humanos; Idoso; Idoso de 80 Anos ou mais; Inibidores da Angiogênese; Estudos Prospectivos; Injeções Intravítreas; Acuidade Visual; Ranibizumab; Receptores de Fatores de Crescimento do Endotélio Vascular; Fatores de Crescimento do Endotélio Vascular; Degeneração Macular/tratamento farmacológico; Proteínas Recombinantes de Fusão/uso terapêutico; Resultado do Tratamento; Degeneração Macular Exsudativa/diagnóstico; Degeneração Macular Exsudativa/tratamento farmacológico

Palavras-chave

Age-related macular degeneration; Faricimab; Real-world data; Treat-and-extend

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Biespecíficos / Degeneração Macular Exsudativa / Degeneração Macular Limite: Aged / Aged80 / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google